Literature DB >> 12461060

Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients.

G Cserni1.   

Abstract

AIMS: To evaluate two detailed step sectioning protocols for sentinel lymph nodes (SLNs).
METHODS: After vital dye or combined dye and radiocolloid guided biopsy, SLNs were fixed in formalin and embedded in paraffin wax. In protocol A, SLNs from 123 patients were sectioned in steps of 50-100 micro m, whereas in protocol B, SLNs from 123 patients were sectioned at steps of 250 micro m. Epithelial marker immunohistochemistry (IHC) was performed on multiple levels in cases with negative haematoxylin and eosin findings.
RESULTS: In groups A and B, 74 and 47 patients were found to have tumour cells in their axillary SLNs, and 19 (28%) and 18 (19%) patients, respectively, were upstaged as compared with the standard histological assessment. Nodal involvement detected by deeper sections was often micrometastatic or in isolated tumour cells
CONCLUSIONS: Serial sectioning and IHC are recommended for the evaluation of SLNs. The optimal extent of the histopathological work up should be studied further.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461060      PMCID: PMC1769842          DOI: 10.1136/jcp.55.12.926

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  50 in total

1.  Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer.

Authors:  C E Cox; S S Bass; C R McCann; N N Ku; C Berman; K Durand; M Bolano; J Wang; E Peltz; S Cox; C Salud; D S Reintgen; G H Lyman
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

2.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

Authors:  K U Chu; R R Turner; N M Hansen; M B Brennan; A Bilchik; A E Giuliano
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

4.  Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma.

Authors:  B Chua; O Ung; R Taylor; M Bilous; E Salisbury; J Boyages
Journal:  Cancer       Date:  2001-10-01       Impact factor: 6.860

5.  Axillary sentinel lymph node examination in breast carcinoma.

Authors:  S W Kelley; R A Komorowski; A M Dayer
Journal:  Arch Pathol Lab Med       Date:  1999-06       Impact factor: 5.534

6.  Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.

Authors:  S Pendas; E Dauway; C E Cox; R Giuliano; N N Ku; R H Schreiber; D S Reintgen
Journal:  Am Surg       Date:  1999-06       Impact factor: 0.688

7.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?

Authors:  C Reynolds; R Mick; J H Donohue; C S Grant; D R Farley; L S Callans; S G Orel; G L Keeney; T J Lawton; B J Czerniecki
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

8.  Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins.

Authors:  J H Kowolik; W Kuhn; J Nährig; M Werner; T Obst; N Avril; M Schmitt; H Graeff
Journal:  Oncol Rep       Date:  2000 Jul-Aug       Impact factor: 3.906

Review 9.  Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Authors:  P L Fitzgibbons; D L Page; D Weaver; A D Thor; D C Allred; G M Clark; S G Ruby; F O'Malley; J F Simpson; J L Connolly; D F Hayes; S B Edge; A Lichter; S J Schnitt
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

10.  Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study.

Authors:  I Jannink; M Fan; S Nagy; G Rayudu; K Dowlatshahi
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

View more
  18 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  A model for determining the optimum histology of sentinel lymph nodes in breast cancer.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  Further axillary metastases associated with isolated tumor cells in sentinel lymph nodes of breast cancer patients.

Authors:  Gabor Cserni
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.

Authors:  Gábor Cserni; Róbert Maráz
Journal:  Pathol Oncol Res       Date:  2015-02-04       Impact factor: 3.201

5.  Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients.

Authors:  Eva V E Madsen; Jan van Dalen; Joost van Gorp; Inne H M Borel Rinkes; Thijs van Dalen
Journal:  Virchows Arch       Date:  2008-06-18       Impact factor: 4.064

Review 6.  Lymph Node Radiotherapy Instead of Extended Axillary Surgery - the New Standard?

Authors:  Peter Niehoff; Silla Hey-Koch
Journal:  Breast Care (Basel)       Date:  2018-06-06       Impact factor: 2.860

7.  Supervised automated microscopy increases sensitivity and efficiency of detection of sentinel node micrometastases in patients with breast cancer.

Authors:  W E Mesker; H Torrenga; W C R Sloos; H Vrolijk; R A E M Tollenaar; P C de Bruin; P J van Diest; H J Tanke
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

8.  Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?

Authors:  Oldrich Coufal; Tomás Pavlík; Pavel Fabian; Rita Bori; Gábor Boross; István Sejben; Róbert Maráz; Jaroslav Koca; Eva Krejcí; Iva Horáková; Vendula Foltinová; Pavlína Vrtelová; Vojtech Chrenko; Wolde Eliza Tekle; Mária Rajtár; Mihály Svébis; Vuk Fait; Gábor Cserni
Journal:  Pathol Oncol Res       Date:  2009-05-15       Impact factor: 3.201

9.  The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.

Authors:  G Cserni; S Bianchi; V Vezzosi; H Peterse; A Sapino; R Arisio; A Reiner-Concin; P Regitnig; J-P Bellocq; C Marin; R Bori; J M Penuela; A Córdoba Iturriagagoitia
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

10.  Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology.

Authors:  G Cserni; I Amendoeira; N Apostolikas; J P Bellocq; S Bianchi; W Boecker; B Borisch; C E Connolly; T Decker; P Dervan; M Drijkoningen; I O Ellis; C W Elston; V Eusebi; D Faverly; P Heikkila; R Holland; H Kerner; J Kulka; J Jacquemier; M Lacerda; J Martinez-Penuela; C De Miguel; J L Peterse; F Rank; P Regitnig; A Reiner; A Sapino; B Sigal-Zafrani; A M Tanous; S Thorstenson; E Zozaya; G Fejes; C A Wells
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.